Literature DB >> 17997770

Treatment of acute corneal hydrops with intracameral C3F8 in a patient of pellucid marginal degeneration with keratoglobus.

Sameer Kaushal1, Namrata Sharma, Rasik B Vajpayee.   

Abstract

We report the use of perfluoropropane (C(3)F(8)) gas for the treatment of acute hydrops with intrastromal cleft in a case of pellucid marginal degeneration with keratoglobus. Acute hydrops in a 36-year-old man with pellucid marginal degeneration with keratoglobus was treated with intracameral injection of 0.3 mL isoexpansile C(3)F(8) (14%). Reduction in corneal haze was seen beginning from the third postoperative day. Significant clearing had taken place by the end of the second week with the closure of intrastromal cleft. Best corrected visual acuity improved from finger counting at 1 foot preoperatively to 6/18 after 2 weeks. There was no postoperative rise in intraocular pressure or cataract formation. Intracameral injection of C(3)F(8) may possibly be a viable treatment option for acute hydrops in a case of corneal ectasia. Larger studies are required to clarify the role of intracameral gas injection in the treatment of acute hydrops in corneal ectasia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997770     DOI: 10.1111/j.1442-9071.2007.01579.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  3 in total

Review 1.  Keratoglobus.

Authors:  B S Wallang; S Das
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

2.  One-step thermokeratoplasty for pain alleviating and pre-treatment of severe acute corneal hydrops in keratoconus.

Authors:  Ran Hao; Yun Feng
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

3.  Descemet stripping endothelial keratoplasty in a patient with keratoglobus and chronic hydrops secondary to a spontaneous descemet membrane tear.

Authors:  Anton M Kolomeyer; David S Chu
Journal:  Case Rep Ophthalmol Med       Date:  2013-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.